Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study
暂无分享,去创建一个
V. Wadley | M. Cushman | S. Judd | F. Unverzagt | N. Zakai | P. Callas | S. Lidofsky | K. Alexander
[1] Sze-Yen Tan,et al. Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review , 2022, BMC Geriatrics.
[2] Yumei Zhang,et al. Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults , 2022, Frontiers in Medicine.
[3] F. Panza,et al. Liver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study , 2021, Frontiers in Aging Neuroscience.
[4] S. Fargion,et al. Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[5] A. Beiser,et al. NON-ALCOHOLIC FATTY LIVER DISEASE, LIVER FIBROSIS SCORE AND COGNITIVE FUNCTION IN MIDDLE-AGED ADULTS: THE FRAMINGHAM STUDY , 2019, Alzheimer's & Dementia.
[6] Xianlin Han,et al. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers , 2019, JAMA network open.
[7] Y. Stern,et al. Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer’s Association Reserve, Resilience and Protective Factors Professional Interest Area working groups , 2019, BMC Medicine.
[8] J. Saver,et al. Striving for Ideal Cardiovascular and Brain Health: It Is Never Too Early or Too Late. , 2018, JAMA.
[9] A. Celikbilek,et al. Cognitive assessment of patients with nonalcoholic fatty liver disease , 2018, European journal of gastroenterology & hepatology.
[10] S. Burgess,et al. Genetically elevated gamma-glutamyltransferase and Alzheimer's disease , 2018, Experimental Gerontology.
[11] M. Cushman,et al. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort , 2018, PloS one.
[12] R. Vasan,et al. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study , 2018, JAMA neurology.
[13] B. Johansson,et al. Gamma-Glutamyltransferase (GGT) as a biomarker of cognitive decline at the end of life: contrasting age and time to death trajectories , 2017, International Psychogeriatrics.
[14] H. Te,et al. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States , 2017, PloS one.
[15] S. Bakker,et al. Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: Interrelationship with age. , 2017, Clinica chimica acta; international journal of clinical chemistry.
[16] B. Balkau,et al. Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies , 2017, Journal of hypertension.
[17] V. Wadley,et al. N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort. , 2016, Journal of Alzheimer's disease : JAD.
[18] J. Laukkanen,et al. Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study , 2016, Alzheimer's & Dementia.
[19] K. Sung,et al. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study , 2016, Medicine.
[20] Jeanne M. Clark,et al. Nonalcoholic fatty liver disease is associated with cognitive function in adults , 2016, Neurology.
[21] F. Vernieri,et al. Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy , 2015, Metabolic Brain Disease.
[22] V. Wadley,et al. Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2015, The Clinical neuropsychologist.
[23] Jimmy D Bell,et al. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. , 2014, European journal of endocrinology.
[24] M. Cushman,et al. Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort. , 2014, Clinical biochemistry.
[25] W. Kernan,et al. Racial Differences in the Association of Insulin Resistance With Stroke Risk: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study , 2014, Stroke.
[26] Hong Liu,et al. Nonalcoholic fatty liver disease and cardiovascular disease. , 2014, World journal of gastroenterology.
[27] Mafalda Bourbon,et al. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[28] B. Kissela,et al. ABO blood type and stroke risk: the REasons for Geographic And Racial Differences in Stroke Study , 2014, Journal of thrombosis and haemostasis : JTH.
[29] B. Stephan,et al. Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.
[30] Raj K. Kalapatapu,et al. Alcohol use biomarkers predicting cognitive performance: a secondary analysis in veterans with alcohol dependence and posttraumatic stress disorder. , 2013, Military medicine.
[31] K. Sikaris,et al. The de ritis ratio: the test of time. , 2013, The Clinical biochemist. Reviews.
[32] Vicente Felipo,et al. Hepatic encephalopathy: effects of liver failure on brain function , 2013, Nature Reviews Neuroscience.
[33] A. Hofman,et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[34] J. Newton,et al. Functional Impairment in Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease Is Significant and Persists over 3 Years of Follow-Up , 2013, Digestive Diseases and Sciences.
[35] J. Newton,et al. Fatigue, Quality of Life, and Psychosocial Issues for People with NAFLD , 2013 .
[36] L. Kuller,et al. Adiposity and Cognitive Decline in the Cardiovascular Health Study , 2013, Neuroepidemiology.
[37] Moshe Leshno,et al. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. , 2013, World journal of gastroenterology.
[38] G. Hankey,et al. Body Adiposity in Later Life and the Incidence of Dementia: The Health in Men Study , 2011, Alzheimer's & Dementia.
[39] V. Howard,et al. Calculating Cornell voltage from nonstandard chest electrode recording site in the Reasons for Geographic And Racial Differences in Stroke study. , 2010, Journal of electrocardiology.
[40] J. Newton. Systemic Symptoms in Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.
[41] Daniele Sancarlo,et al. Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. , 2010, Journal of Alzheimer's disease : JAD.
[42] L. Wilkins. Association between late-life body mass index and dementia: The Kame Project , 2009, Neurology.
[43] E. Larson,et al. Association between late-life body mass index and dementia , 2009, Neurology.
[44] Beverley Balkau,et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population , 2009, Hepatology.
[45] Lewis H Kuller,et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. , 2009, Archives of neurology.
[46] E. Barrett-Connor,et al. Central obesity and increased risk of dementia more than three decades later , 2008, Neurology.
[47] A. D. de Craen,et al. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old , 2007, Neurology.
[48] C. Moy,et al. Cognitive Status, Stroke Symptom Reports, and Modifiable Risk Factors Among Individuals With No Diagnosis of Stroke or Transient Ischemic Attack in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2007, Stroke.
[49] K. Yaffe,et al. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. , 2007, Current Alzheimer research.
[50] R. Mayeux,et al. Measures of adiposity and dementia risk in elderly persons. , 2007, Archives of neurology.
[51] Anna Castiglione,et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.
[52] Federica Agostini,et al. Nonalcoholic fatty liver disease and the metabolic syndrome , 2005, Current opinion in lipidology.
[53] C. Moy,et al. The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and Design , 2005, Neuroepidemiology.
[54] A. Collie. Cognition in liver disease , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[55] Christopher M Callahan,et al. Six-Item Screener to Identify Cognitive Impairment Among Potential Subjects for Clinical Research , 2002, Medical care.
[56] A. Heyman,et al. Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery , 2001, Journal of the International Neuropsychological Society.